Signos Unveils First Ever FDA-Cleared Glucose Monitoring Breakthrough for Weight Management, Enabling Millions of Americans to Take Control of Their Health

PALO ALTO, Calif., Aug. 20, 2025 /PRNewswire/ -- Signos, a purpose-driven metabolic health platform committed to transforming lives through personalized, real-time insights, today announced the launch of Signos Glucose Monitoring System, the first ever FDA-cleared, over-the-counter glucose monitoring system for weight management.

At a time when obesity and disease threaten the well-being of millions, Signos is leading the movement to put metabolic health back into the hands of individuals. By integrating Stelo by Dexcom glucose biosensor with an AI-powered platform for deciphering unique metabolisms, Signos enables people to see how food choices, timing, activity, stress, and even sleep affect their bodies in real time — equipping them with the information required to seize their health and make decisions backed by their own biology.

"This is more than a product launch — it's a mission," said Sharam Fouladgar-Mercer, CEO and Founder of Signos. "Everyone deserves access to insights that help them live healthier, longer, more vibrant lives. Signos isn't just about data; it's about giving people ownership over their health and weight journeys in a way never before seen."

Key Features and Purpose-Driven Benefits:

• Igniting the Metabolic Movement with Personalized Data: By tapping into the body's own signals, Signos equips individuals with tools to improve sleep, manage weight, and reduce the risk of chronic disease — not through restriction, but through understanding.
• Personalized, AI-Driven Insights: Signos translates glucose fluctuations into easy-to-follow, personalized recommendations — transforming raw data into actionable guidance for building healthier everyday habits.
• Total Body Intelligence: Signos helps users understand how their bodies respond to meals, workouts, sleep, and stress, creating a holistic picture of personal health.
• Expert Metabolic Monitoring: Signos removes barriers and puts powerful glucose insights into the hands of millions without the need for prescriptions, inflated prices, or hidden hoops. It's real-time metabolic health, made truly accessible.

The need for accessible, effective metabolic health solutions has never been greater. With 73.6% of U.S. adults classified as overweight or obese, 88% of Americans classified as metabolically unhealthy, and global diabetes diagnoses projected to reach 1.3 billion by 2050, Signos offers a proactive solution grounded in science and is changing the trajectory of metabolic health by intervening early and guiding users toward meaningful, lasting lifestyle changes. The company aims to help millions monitor their metabolic health and build better habits by leveraging insights based on glucose, the body's primary energy source.

Raven-Symoné, actress and advisor, shared, "I've been using Signos for years now and no matter my mental ups and downs it is there to keep me in reality. The reality is things change, levels change, but if you keep an eye on the overall picture you can keep your health in the green. Signos gives me the confidence to enjoy life while being mindful of my body and what it needs."

Signos is available now, offering individuals everywhere a revolutionary way to monitor glucose, unlock personalized insights, and take control of their metabolism to build a sustainably healthier life — all from the convenience of their smartphone. For more information, visit signos.com.

About Signos

Launched in 2018, Signos, Inc. is on a mission to eliminate obesity by igniting the metabolic health movement. Powered by a continuous glucose monitor (CGM), the company's mobile AI-driven system offers personalized insights into how food, movement, sleep, stress, and more affect each unique body enabling people to seize their health.

With over 73% of Americans overweight or obese, Signos offers a science-backed path to sustainable weight management through the lens of individual metabolism. Founded by experts in data science, AI, and behavioral design, the company is committed to building technology that drives better health outcomes.

SOURCE Signos